L
Luciano Vio
Researcher at University of Trieste
Publications - 47
Citations - 1426
Luciano Vio is an academic researcher from University of Trieste. The author has contributed to research in topics: Antimycobacterial & Mycobacterium tuberculosis. The author has an hindex of 23, co-authored 47 publications receiving 1376 citations.
Papers
More filters
Journal ArticleDOI
Antimycobacterial activity of new 3-substituted 5-(pyridin-4-yl)-3H-1,3,4-oxadiazol-2-one and 2-thione derivatives. Preliminary molecular modeling investigations.
Maria Grazia Mamolo,Daniele Zampieri,Luciano Vio,Maurizio Fermeglia,Marco Ferrone,Sabrina Pricl,Giuditta Scialino,Elena Banfi +7 more
TL;DR: Molecular modeling investigations showed that the active compounds may interact at the active site of the mycobacterial cytochrome P450-dependent sterol 14alpha-demethylase in the sterol biosynthesis pathway and that their binding free energy values are in agreement with their MIC values.
Journal ArticleDOI
Synthesis and antimycobacterial activity of [5-(pyridin-2-yl)-1,3,4-thiadiazol-2-ylthio]acetic acid arylidene-hydrazide derivatives.
TL;DR: [5-(Pyridin-2-yl)-1,3,4-thiadiazol- 2-ylthio]acetic acid arylidene-hydrazide derivatives were synthesized and tested for their in vitro antimycobacterial activity and some compounds showed a feable activity against a strain of Mycobacterium tuberculosis.
Journal ArticleDOI
Homology Model and Docking-Based Virtual Screening for Ligands of the σ1 Receptor.
Erik Laurini,Valentina Dal Col,Maria Grazia Mamolo,Daniele Zampieri,Paola Posocco,Maurizio Fermeglia,Luciano Vio,Sabrina Pricl +7 more
TL;DR: This study presents for the first time the 3D model of the σ1 receptor protein as obtained from homology modeling techniques, shows the applicability of this structure to docking-based virtual screening, and defines a computational strategy to optimize the results based on a combination of 3D pharmacophore-based docking and MM/PBSA free energy of binding scoring.
Journal Article
Synthesis and antimicrobial activity of some 2,5-disubstituted 1,3,4,-thiadiazole derivatives.
TL;DR: In this article, a series of 5-substituted 2-arylamino-1,3,4-thiadiazole derivatives was prepared and the antimicrobial activity of these compounds against some strains of bacteria and a strain of Candida albicans was determined, together with that of corresponding thiosemicarbazone derivatives, which are intermediates in the synthetical procedure.
Journal ArticleDOI
Antifungal and antimycobacterial activity of new imidazole and triazole derivatives. A combined experimental and computational approach
Elena Banfi,Giuditta Scialino,Daniele Zampieri,Maria Grazia Mamolo,Luciano Vio,Marco Ferrone,Maurizio Fermeglia,Maria Silvia Paneni,Sabrina Pricl +8 more
TL;DR: Molecular modelling investigations showed that the active new compounds may interact at the active site of both the fungal and the mycobacterial cytochrome P450-dependent sterol-14alpha-demethylase and that the calculated binding free energy values are in agreement with the corresponding MIC values.